Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

LL-37

Cathelicidin, hCAP-18, FALL-39, CAP-18

Quick Stats
Studies 2230
Trials 95
Score 3
2023 pubmed

Insulin Stimulates IL-23 Expression in Human Adipocytes: A Possible Explanation for the Higher Prevalence of Psoriasis in Obesity.

Di Vincenzo. Angelo A; Granzotto. Marnie M; Crescenzi. Marika M; Costa. Camilla C; Piaserico. Stefano S; Vindigni. Vincenzo V; Vettor. Roberto R; Rossato. Marco M

Key Findings

  • Human adipocytes express IL‑23 mRNA and protein under normal conditions.
  • Insulin increases IL‑23 expression in adipocytes in a dose‑dependent manner.
  • Insulin’s effect is specific; it does not raise other psoriasis‑related cytokines such as IL‑22 or the peptide LL‑37.

Practical Outcomes

  • For biohackers, the takeaway is that keeping insulin levels low—through weight management, low‑carb diets, intermittent fasting, or insulin‑sensitizing agents—might reduce IL‑23 driven inflammation and potentially improve psoriasis symptoms. However, the findings are from cell‑culture experiments, so real‑world effects need clinical confirmation.

Summary

The study shows that human fat cells naturally make the inflammation signal IL‑23, and that insulin makes them produce even more of it. This effect is specific to insulin and not seen with other triggers like bacterial components. Because high insulin levels are common in obesity, this may help explain why people who are overweight often have worse psoriasis.

Abstract

Psoriasis is a chronic systemic inflammatory disease involving the production of many pro-inflammatory cytokines derived from immune cells and interacting with different tissues leading to the typical skin lesions. Psoriasis shows a higher prevalence and a worse progression in obese than in lean subjects. The IL-23/IL-17 immune axis has a pivotal role in the pathogenesis of psoriasis and anti-IL-23 monoclonal antibodies are highly effective in its treatment. Since obesity in frequently associated with elevated insulin plasma levels, we have investigated the ability of in vitro differentiated human adipocytes to produce IL-23 at basal conditions and after insulin stimulation. In vitro differentiated human adipocytes were incubated in the absence and presence of different insulin concentrations and the expression of IL-23 was analyzed by real-time PCR and Western blotting. The results of this study show that in vitro differentiated human adipocytes spontaneously express IL-23 mRNA and protein being stimulated by insulin in a dose-dependent manner. The stimulatory effects of insulin on IL-23 expression were specific since it did not stimulate the expression of other well-known cytokines involved in psoriasis pathogenesis such as Il-22 nor LL-37. Furthermore, lipopolysaccharide did not stimulate IL-23 expression in human adipocytes, thus highlightening the specific effects of insulin in the stimulation of IL-23 expression in human adipocytes. Here we show that human adipocytes spontaneously express IL-23 and that insulin stimulates IL-23 production by these cells in a specific manner as other stimuli, known to be involved in psoriasis pathophysiology, are ineffective. These observations could explain the association between psoriasis and obesity, a condition frequently characterized by a state of insulin hypersecretion.

Study Information

Provider

pubmed

Year

2023

Date

2023-06-23T00:00:00.000Z

DOI

10.2147/dmso.s405374